Kininogen HC Antibodies

Santa Cruz Biotechnology offers a broad range of Kininogen HC monoclonal antibodies for investigating kininogen in various biological processes. Kininogen HC monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Kininogen is a key plasma protein involved in the regulation of blood pressure and inflammation, serving as a precursor to kinins, which are peptides that play important roles in vasodilation and pain signaling. The study of Kininogen HC is essential for elucidating its involvement in cardiovascular diseases and inflammatory responses. Understanding the function of Kininogen HC can provide insights into therapeutic targets for managing various conditions. Researchers worldwide rely on Kininogen HC monoclonal antibodies to advance their studies in cardiovascular and inflammatory research. Kininogen HC monoclonal antibodies enable precise detection and analysis of protein expression, localization, and interactions in diverse experimental settings. Santa Cruz Biotechnology monoclonal antibodies for Kininogen HC support researchers in making meaningful contributions to understanding cardiovascular health and disease mechanisms.